San Donato Hospital
CyberKnife for brain tumor in Italy typically costs from $40,000 to $60,000. The final price depends on tumor complexity, number of treatment sessions, and clinic location. In the US, similar procedures cost around $95,000 on average. Italy offers savings of around 47%. Treatment usually includes radiotherapy planning, immobilization mask creation, and automated dose delivery.
Bookimed Expert Insight: Choosing an IRCCS-accredited facility like San Raffaele or San Donato ensures high-value care. These Milan-based centers handle over 300,000 patients annually and hold Newsweek's World's Best Hospitals status. While complex cases may cost approximately $41,150, patients benefit from pioneering technology. This volume-driven expertise provides a reliable balance between investment and clinical precision in neuro-oncology.
Why consider Italy for CyberKnife treatment of brain tumors?
Access advanced CyberKnife for brain tumor solutions in trusted clinics .
| Italy | Turkey | Austria | |
| CyberKnife for brain tumor | from $40,000 | from $4,750 | from $35,000 |
Day 1
Day 2
Day 3
Day 4
Day 5
Day 6
Day 7
Weeks 1-2
Week 3
Week 4
Please note that this is a general plan and each case is individual.
The doctor is a renowned Italian neurosurgeon with over 30 years of experience, currently serving patients at Ospedale San Raffaele and directing the Experimental Neurosurgery Unit at San Raffaele Scientific Institute. Additionally, the doctor is a Visiting Professor at George Washington University in the USA.
Graduating from the University of Milan and the University of Verona, the doctor specializes in neuro- and radiosurgeries with a focus on minimally invasive spine and brain operations. These procedures utilize neuronavigation and neuromapping to enhance precision and recovery.
The doctor has patented a device for regenerating biological tissues and has conducted groundbreaking surgeries, including a unique spina bifida treatment in an unborn child.
This non-invasive treatment uses precision radiation therapy to target brain tumors with high accuracy.